Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle M Brennan

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Circulation|September 28, 2011
Impact of exercise on heart rate recoveryMichael A Jolly, Danielle M Brennan, Leslie Cho
The Journal of Cardiovascular Nursing|February 20, 2010
High school body mass index and body mass index at entry to a cardiac disease risk prevention clinic and the association to all-cause mortality and coronary heart disease: a PreCIS database studyKatherine K Gambino, Julia Zumpano, Danielle M Brennan, et al.
Obesity (Silver Spring, Md.)|December 26, 2009
The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database studyAdriana G Ioachimescu, Danielle M Brennan, Brian M Hoar, et al.
Journal of Women'S Health (2002)|March 19, 2008
Gender differences in utilization of effective cardiovascular secondary prevention: a Cleveland clinic prevention database studyLeslie Cho, Byron Hoogwerf, Julie Huang, et al.
Journal of the American College of Cardiology|March 7, 2006
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary interventionSteven R Steinhubl, Peter B Berger, Danielle M Brennan, et al.
European Journal of Internal Medicine|June 20, 2017
Comparing SF-36® scores versus biomarkers to predict mortality in primary cardiac prevention patientsRony Lahoud, Vasutakarn Chongthammakun, Yuping Wu, et al.
Preventive Cardiology|July 15, 2010
Association of SF-36 with coronary artery disease risk factors and mortality: a PreCIS studyJian-Ping Zhang, Leo Pozuelo, Danielle M Brennan, et al.
Thyroid : Official Journal of the American Thyroid Association|July 13, 2011
Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database studyChristine McQuade, Mario Skugor, Danielle M Brennan, et al.
Journal of the American College of Cardiology|May 30, 2009
Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular riskW H Wilson Tang, Zeneng Wang, Leslie Cho, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 23, 2009
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibitionZeneng Wang, W H Wilson Tang, Leslie Cho, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Circulation|September 28, 2011
Impact of exercise on heart rate recoveryMichael A Jolly, Danielle M Brennan, Leslie Cho
The Journal of Cardiovascular Nursing|February 20, 2010
High school body mass index and body mass index at entry to a cardiac disease risk prevention clinic and the association to all-cause mortality and coronary heart disease: a PreCIS database studyKatherine K Gambino, Julia Zumpano, Danielle M Brennan, et al.
Obesity (Silver Spring, Md.)|December 26, 2009
The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database studyAdriana G Ioachimescu, Danielle M Brennan, Brian M Hoar, et al.
Journal of Women'S Health (2002)|March 19, 2008
Gender differences in utilization of effective cardiovascular secondary prevention: a Cleveland clinic prevention database studyLeslie Cho, Byron Hoogwerf, Julie Huang, et al.
Journal of the American College of Cardiology|March 7, 2006
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary interventionSteven R Steinhubl, Peter B Berger, Danielle M Brennan, et al.
European Journal of Internal Medicine|June 20, 2017
Comparing SF-36® scores versus biomarkers to predict mortality in primary cardiac prevention patientsRony Lahoud, Vasutakarn Chongthammakun, Yuping Wu, et al.
Preventive Cardiology|July 15, 2010
Association of SF-36 with coronary artery disease risk factors and mortality: a PreCIS studyJian-Ping Zhang, Leo Pozuelo, Danielle M Brennan, et al.
Thyroid : Official Journal of the American Thyroid Association|July 13, 2011
Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database studyChristine McQuade, Mario Skugor, Danielle M Brennan, et al.
Journal of the American College of Cardiology|May 30, 2009
Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular riskW H Wilson Tang, Zeneng Wang, Leslie Cho, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 23, 2009
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibitionZeneng Wang, W H Wilson Tang, Leslie Cho, et al.
Pageof 7